John Chalmers AC's Publications

Wang X, Moullaali TJ, Li Q et alii
Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients

Journal articles
2020
Stroke
Harris K, Oshima M, Sattar N et alii
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study

Journal articles
2020
Diabetologia
Hua X, Lung TWC, Woodward M et alii
Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials

Journal articles
2020
Diabetic Medicine
Tian J, Ohkuma T, Cooper M et alii
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial

Journal articles
2020
Diabetes care
Lee CMY, Woodward M, Batty GD et alii
Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta-analysis consisting 2.8 million adults with 57 294 cases of dementia

Journal articles
2020
Obesity Reviews
Chalmers J, Woodward M
Observational analyses from ADVANCE and ADVANCE-ON

Journal articles
2020
Diabetes
Caleres G, Modig S, Midlöv P et alii
Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many Drugs

Journal articles
2020
Drugs - Real World Outcomes
Godolphin PJ, Bath PM, Algra A et alii
Cost-benefit of outcome adjudication in nine randomised stroke trials

Journal articles
2020
Clinical Trials
Zhou Z, Zhou Z, Yoshimura S et alii
Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries

Journal articles
2020
Stroke
Ohkuma T, Peters SAE, Jun M et alii
Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study

Journal articles
2020
Diabetes
Sharman JE, O'Brien E, Alpert B et alii
Lancet Commission on Hypertension Group position statement on the global improvement of accuracy standards for devices that measure blood pressure

Journal articles
2020
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH
Chen X, Li J, Anderson CS et alii
Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm

Journal articles
2020
International Journal of Stroke
Lee AK, Woodward M, Wang D et alii
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE

Journal articles
2020
The Journal of clinical endocrinology and metabolism
Chalmers J
Could We Make Better Use of Raised Blood Pressure Readings in the Emergency Department?

Journal articles
2020
Hypertension (Dallas
Chen X, Wang X, Delcourt C et alii
Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial

Journal articles
2020
Stroke
Wang X, Song L, Yang J et alii
Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study

Journal articles
2020
Cerebrovascular Diseases
Sharman JE, O'Brien E, Alpert B et alii
Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

Journal articles
2020
Journal of Hypertension
Wang X, Lee KJ, Moullaali TJ et alii
Who will benefit more from low-dose alteplase in acute ischemic stroke?

Journal articles
2020
International Journal of Stroke
Peters R, Yasar S, Anderson CS et alii
An investigation of antihypertensive class, dementia, and cognitive decline

Journal articles
2020
Neurology
Carcel C, Wang X, Sandset EC et alii
Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants

Journal articles
2019
Neurology
Carcel C, Neal B, Oparil S et alii
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The Survey of PatIents with treatment ResIstant hyperTension study

Journal articles
2019
Journal of Hypertension
Oshima M, Jun M, Ohkuma T et alii
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

Journal articles
2019
Diabetologia
Robinson TG, Bray BD, Paley L et alii
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

Journal articles
2019
International Journal of Stroke
Zhou Z, Yoshimura S, Delcourt C et alii
Thrombolysis outcomes in acute ischemic stroke by FLAIR hyper intense arteries

Conference Abstracts
2019
in INTERNATIONAL JOURNAL OF STROKE
Freed R, Lim J, De Silva A et alii
Triple therapy prevention of Recurrent Intracerebral Disease Events Trial (TRIDENT): Prior medical history and BP lowering medication use

Conference Abstracts
2019
in INTERNATIONAL JOURNAL OF STROKE

John Chalmers AC's Publications

Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients

Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study

Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials

Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial

Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta-analysis consisting 2.8 million adults with 57 294 cases of dementia

Observational analyses from ADVANCE and ADVANCE-ON

Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many Drugs

Cost-benefit of outcome adjudication in nine randomised stroke trials

Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries

Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study

Lancet Commission on Hypertension Group position statement on the global improvement of accuracy standards for devices that measure blood pressure

Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm

The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE

Could We Make Better Use of Raised Blood Pressure Readings in the Emergency Department?

Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial

Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study

Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

Who will benefit more from low-dose alteplase in acute ischemic stroke?

An investigation of antihypertensive class, dementia, and cognitive decline

Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants

Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The Survey of PatIents with treatment ResIstant hyperTension study

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

Thrombolysis outcomes in acute ischemic stroke by FLAIR hyper intense arteries

Triple therapy prevention of Recurrent Intracerebral Disease Events Trial (TRIDENT): Prior medical history and BP lowering medication use

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country